141080.KQ
LigaChem Biosciences Inc.
KOE · Healthcare · Biotechnology · KR
KRW 88,300.00
−2.75%Year over year
Reported trailing growth
- Revenue
- -33.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +82.7%
- EBITDA
- +88.8%
- EPS
- +86.4%
Three-year CAGR
- Revenue
- +61.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026